Fortis Healthcare Ltd (FORTIS)
🎯 Key Takeaways
- Revenue grew 7.6% QoQ to ₹2,545 in Q1FY27.
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 2,331 | 2,265 | 2,365 | 2,545 |
| Operating Profit | 450 | 386 | 410 | 415 |
| OPM % | 19.3% | 17.0% | 17.4% | 16.3% |
| Net Profit | 329 | 197 | 271 | 273 |
| EPS | ₹4.26 | ₹2.57 | ₹3.52 | ₹3.53 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 755 | 755 | 755 | 755 |
| Reserves | 7,092 | 8,162 | 8,674 | 9,141 |
| Borrowings | 1,187 | 2,475 | 3,195 | 2,873 |
| Total Liabilities | 13,597 | 13,692 | 15,013 | 15,966 |
| Fixed Assets | 5,578 | 5,848 | 6,599 | 12,232 |
| Investments | 175 | 169 | 220 | 243 |
| Total Assets | 13,597 | 13,692 | 15,013 | 15,966 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +1,601 |
| Investing | -1,538 |
| Financing | +164 |
| Net Cash Flow | +228 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 31.2% | 31.2% | 31.2% | 31.2% |
| FII | 27.9% | 27.8% | 26.0% | 25.2% |
| DII | 29.1% | 29.3% | 31.4% | 32.2% |
| Public | 10.1% | 10.1% | 10.0% | 9.9% |
| # Shareholders | 2,20,766 | 2,33,156 | 2,26,685 | 2,20,743 |
⚖️ Peer Comparison — Healthcare
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.27 L Cr | 60.9 | 22.1% | 22.9% | 0.60 |
| MANIPALHOS | 1.02 L Cr | — | — | — | 1.25 |
| MAXHEALTH | 98,594 | 67.6 | 14.4% | 13.6% | 0.27 |
| FORTIS | 70,211 | 67.0 | 13.3% | 10.8% | 0.29 |
| ASTERDM | 64,953 | 120.6 | 17.2% | 11.9% | 0.21 |
| MEDANTA | 39,538 | 71.0 | 21.9% | 16.3% | 0.10 |
| NH | 39,475 | 48.1 | 13.7% | 18.0% | 1.07 |
| LALPATHLAB | 32,366 | 46.5 | 29.6% | 21.8% | 0.00 |
| KIMS | 32,332 | 150.9 | 9.7% | 8.7% | 1.44 |
| POLYMED | 17,553 | 55.7 | 15.1% | 11.3% | 0.06 |
🔗 Peer Stock Analyses
📋 Recent Filings
-
Announcement 24 August 2026Fortis Healthcare announced it received an ESG rating of Crisil ESG 66 and Crisil Core ESG 72 for FY2025-26 from Crisil ESG Ratings & Analytics Ltd, c...
-
🟡 Board Meeting 11 August 2026Fortis Healthcare held its 30th Annual General Meeting on August 11, 2026 via video conference, where shareholders approved the audited financial stat...
-
🔴 Financial Results 11 August 2026Fortis Healthcare reported consolidated revenue of **₹2,545 crores** in Q1 FY27, up 17.5% YoY, with net profit after tax at **₹263 crores**, up ~4%. O...
-
🔴 Financial Results 7 August 2026Fortis Healthcare announced an investor and analyst meeting held on August 7, 2026 to discuss its unaudited standalone and consolidated financial resu...
-
🟡 Board Meeting 5 August 2026Fortis Healthcare announced that its subsidiary Agilus Diagnostics approved merging two wholly owned entities, Agilus Pathlabs Private Limited and DDR...
-
Announcement 31 July 2026Fortis Healthcare announced a revised schedule for its investor and analyst conference call to discuss unaudited Q1FY27 results, now set for August 7,...
-
Announcement 30 July 2026Fortis Healthcare announced a virtual conference call on August 7, 2026 at 11:00 am IST to discuss unaudited Q1FY27 financial results, inviting analys...
-
🟡 Board Meeting 21 July 2026Fortis Healthcare announced a recommended final dividend of Rs 1 per share for FY2026, payable after AGM approval on August 11, 2026, subject to TDS u...
-
Announcement 20 July 2026Fortis Healthcare announced the appointment of Vijender Singh as Managing Director and CEO of its subsidiary Agilus Diagnostics, effective July 20, 20...
-
share transfer 8 July 2026Fortis Healthcare received certificates from Kfin Technologies confirming dematerialization/rematerialization of shares for the quarter ended June 30,...
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when FORTIS files new disclosures
Track FORTIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FORTIS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd